REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 48 filers reported holding REGULUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,000 | 0.0% | 6,407 | -9.3% | 0.00% | – |
| Q4 2021 | $2,000 | -60.0% | 7,063 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -16.7% | 7,063 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | -45.5% | 7,063 | 0.0% | 0.00% | – |
| Q1 2021 | $11,000 | +22.2% | 7,063 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | +125.0% | 7,063 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -20.0% | 7,063 | -1.7% | 0.00% | – |
| Q2 2020 | $5,000 | +66.7% | 7,188 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -50.0% | 7,188 | -0.6% | 0.00% | – |
| Q4 2019 | $6,000 | +20.0% | 7,229 | -0.2% | 0.00% | – |
| Q3 2019 | $5,000 | -50.0% | 7,245 | -8.4% | 0.00% | – |
| Q2 2019 | $10,000 | +25.0% | 7,911 | -1.5% | 0.00% | – |
| Q1 2019 | $8,000 | 0.0% | 8,035 | -4.9% | 0.00% | – |
| Q4 2018 | $8,000 | – | 8,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 1,450,777 | $1,180,000 | 0.81% |
| Endurant Capital Management LP | 2,607,674 | $2,120,000 | 0.58% |
| Sarissa Capital Management LP | 1,851,851 | $1,506,000 | 0.12% |
| Ikarian Capital, LLC | 1,245,989 | $1,014,000 | 0.08% |
| NEA Management Company, LLC | 6,451,056 | $5,225,000 | 0.07% |
| Focused Wealth Management, Inc | 200,000 | $163,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 206,265 | $168,000 | 0.02% |
| GYL FINANCIAL SYNERGIES, LLC | 41,000 | $33,000 | 0.02% |
| Virtu Financial LLC | 79,193 | $64,000 | 0.01% |
| Pinz Capital Management, LP | 22,300 | $18,000 | 0.01% |